In conclusion, we found that lncRNA MIAT knockdown inhibited cell proliferation and induced apoptosis in prostate cancer through miR-361-3p/CCAR2 axis and participated in prostate cancer, which would provide new targets for the treatment of prostate cancer. Here, CCAR2 is linked to prostate carcinoma.